Virtual event

Discover the MxP® Quant 1000 kit that was designed to address the pressing issue of complex chronic diseases with metabolomics. In this talk, you’ll learn all about the choice of the metabolites and pathways that came in the creation of this new standard of excellence. You’ll also see concrete examples of how to apply the kit to screen samples, leverage data and translate insights into the solutions you need for your research.

Get an in-depth look at the MxP® Quant 1000 kit technology from its product manager, who will demonstrate how you benefit from its validated methods, ready-to-use components, and AI-powered workflow manager. Learn how the extensive coverage combined with high analytical precision from minimal sample volume delivers deep biological insights for fundamental, pharmaceutical, and clinical research.

Despite the effectiveness of antiretroviral therapy (ART) in treating and preventing HIV infection, people with HIV (PWH) often experience chronic inflammation that contributes to the development of inflammatory-mediated comorbidities such as cardiovascular disease and cancer. This risk is especially elevated in PWH that have poor T cell recovery, termed immunological non-responders, despite sustained viral suppression. Here, we investigate the mechanisms driving chronic inflammation during ART using the biocrates MxP Quant 1000 platform to deeply profile the plasma metabolome of PWH and healthy controls. Our goal is to identify potential interventions that can mitigate chronic inflammation and reduce the occurence of comorbidities in PWH.